Tags

Type your tag names separated by a space and hit enter

Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial.
JAMA Intern Med. 2014 May; 174(5):671-7.JIM

Abstract

IMPORTANCE

Current tobacco use treatment approaches require smokers to request treatment or depend on the provider to initiate smoking cessation care and are therefore reactive. Most smokers do not receive evidence-based treatments for tobacco use that include both behavioral counseling and pharmacotherapy.

OBJECTIVE

To assess the effect of a proactive, population-based tobacco cessation care model on use of evidence-based tobacco cessation treatments and on population-level smoking cessation rates (ie, abstinence among all smokers including those who use and do not use treatment) compared with usual care among a diverse population of current smokers.

DESIGN, SETTING, AND PARTICIPANTS

The Veterans Victory Over Tobacco Study, a pragmatic randomized clinical trial involving a population-based registry of current smokers aged 18 to 80 years. A total of 6400 current smokers, identified using the Department of Veterans Affairs (VA) electronic medical record, were randomized prior to contact to evaluate both the reach and effectiveness of the proactive care intervention.

INTERVENTIONS

Current smokers were randomized to usual care or proactive care. Proactive care combined (1) proactive outreach and (2) offer of choice of smoking cessation services (telephone or in-person). Proactive outreach included mailed invitations followed by telephone outreach to motivate smokers to seek treatment with choice of services.

MAIN OUTCOMES AND MEASURES

The primary outcome was 6-month prolonged smoking abstinence at 1 year and was assessed by a follow-up survey among all current smokers regardless of interest in quitting or treatment utilization.

RESULTS

A total of 5123 participants were included in the primary analysis. The follow-up survey response rate was 66%. The population-level, 6-month prolonged smoking abstinence rate at 1 year was 13.5% for proactive care compared with 10.9% for usual care (P = .02). Logistic regression mixed model analysis showed a significant effect of the proactive care intervention on 6-month prolonged abstinence (odds ratio [OR], 1.27 [95% CI, 1.03-1.57]). In analyses accounting for nonresponse using likelihood-based not-missing-at-random models, the effect of proactive care on 6-month prolonged abstinence persisted (OR, 1.33 [95% CI, 1.17-1.51]).

CONCLUSIONS AND RELEVANCE

Proactive, population-based tobacco cessation care using proactive outreach to connect smokers to evidence-based telephone or in-person smoking cessation services is effective for increasing long-term population-level cessation rates.

TRIAL REGISTRATION

clinicaltrials.gov Identifier: NCT00608426.

Authors+Show Affiliations

Center for Chronic Disease Outcomes Research, a VA Health Services Research and Development Center of Innovation, Minneapolis VA Health Care System, Minneapolis, Minnesota2Department of Medicine, University of Minnesota Medical School, Minneapolis.Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota.VA New York Harbor Healthcare System, New York5Division of General Internal Medicine, New York University School of Medicine, New York.Center for Chronic Disease Outcomes Research, a VA Health Services Research and Development Center of Innovation, Minneapolis VA Health Care System, Minneapolis, Minnesota2Department of Medicine, University of Minnesota Medical School, Minneapolis.Center for Chronic Disease Outcomes Research, a VA Health Services Research and Development Center of Innovation, Minneapolis VA Health Care System, Minneapolis, Minnesota2Department of Medicine, University of Minnesota Medical School, Minneapolis.Center for Chronic Disease Outcomes Research, a VA Health Services Research and Development Center of Innovation, Minneapolis VA Health Care System, Minneapolis, Minnesota.Center for Chronic Disease Outcomes Research, a VA Health Services Research and Development Center of Innovation, Minneapolis VA Health Care System, Minneapolis, Minnesota2Department of Medicine, University of Minnesota Medical School, Minneapolis.James A. Haley Veterans Hospital, Tampa, Florida7University of South Florida College of Medicine, Tampa.G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi.Department of Medicine, University of Minnesota Medical School, Minneapolis.

Pub Type(s)

Comparative Study
Journal Article
Multicenter Study
Pragmatic Clinical Trial
Randomized Controlled Trial
Research Support, U.S. Gov't, Non-P.H.S.

Language

eng

PubMed ID

24615217

Citation

Fu, Steven S., et al. "Proactive Tobacco Treatment and Population-level Cessation: a Pragmatic Randomized Clinical Trial." JAMA Internal Medicine, vol. 174, no. 5, 2014, pp. 671-7.
Fu SS, van Ryn M, Sherman SE, et al. Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial. JAMA Intern Med. 2014;174(5):671-7.
Fu, S. S., van Ryn, M., Sherman, S. E., Burgess, D. J., Noorbaloochi, S., Clothier, B., Taylor, B. C., Schlede, C. M., Burke, R. S., & Joseph, A. M. (2014). Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial. JAMA Internal Medicine, 174(5), 671-7. https://doi.org/10.1001/jamainternmed.2014.177
Fu SS, et al. Proactive Tobacco Treatment and Population-level Cessation: a Pragmatic Randomized Clinical Trial. JAMA Intern Med. 2014;174(5):671-7. PubMed PMID: 24615217.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial. AU - Fu,Steven S, AU - van Ryn,Michelle, AU - Sherman,Scott E, AU - Burgess,Diana J, AU - Noorbaloochi,Siamak, AU - Clothier,Barbara, AU - Taylor,Brent C, AU - Schlede,Carolyn M, AU - Burke,Randy S, AU - Joseph,Anne M, PY - 2014/3/12/entrez PY - 2014/3/13/pubmed PY - 2014/6/25/medline SP - 671 EP - 7 JF - JAMA internal medicine JO - JAMA Intern Med VL - 174 IS - 5 N2 - IMPORTANCE: Current tobacco use treatment approaches require smokers to request treatment or depend on the provider to initiate smoking cessation care and are therefore reactive. Most smokers do not receive evidence-based treatments for tobacco use that include both behavioral counseling and pharmacotherapy. OBJECTIVE: To assess the effect of a proactive, population-based tobacco cessation care model on use of evidence-based tobacco cessation treatments and on population-level smoking cessation rates (ie, abstinence among all smokers including those who use and do not use treatment) compared with usual care among a diverse population of current smokers. DESIGN, SETTING, AND PARTICIPANTS: The Veterans Victory Over Tobacco Study, a pragmatic randomized clinical trial involving a population-based registry of current smokers aged 18 to 80 years. A total of 6400 current smokers, identified using the Department of Veterans Affairs (VA) electronic medical record, were randomized prior to contact to evaluate both the reach and effectiveness of the proactive care intervention. INTERVENTIONS: Current smokers were randomized to usual care or proactive care. Proactive care combined (1) proactive outreach and (2) offer of choice of smoking cessation services (telephone or in-person). Proactive outreach included mailed invitations followed by telephone outreach to motivate smokers to seek treatment with choice of services. MAIN OUTCOMES AND MEASURES: The primary outcome was 6-month prolonged smoking abstinence at 1 year and was assessed by a follow-up survey among all current smokers regardless of interest in quitting or treatment utilization. RESULTS: A total of 5123 participants were included in the primary analysis. The follow-up survey response rate was 66%. The population-level, 6-month prolonged smoking abstinence rate at 1 year was 13.5% for proactive care compared with 10.9% for usual care (P = .02). Logistic regression mixed model analysis showed a significant effect of the proactive care intervention on 6-month prolonged abstinence (odds ratio [OR], 1.27 [95% CI, 1.03-1.57]). In analyses accounting for nonresponse using likelihood-based not-missing-at-random models, the effect of proactive care on 6-month prolonged abstinence persisted (OR, 1.33 [95% CI, 1.17-1.51]). CONCLUSIONS AND RELEVANCE: Proactive, population-based tobacco cessation care using proactive outreach to connect smokers to evidence-based telephone or in-person smoking cessation services is effective for increasing long-term population-level cessation rates. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00608426. SN - 2168-6114 UR - https://www.unboundmedicine.com/medline/citation/24615217/Proactive_tobacco_treatment_and_population_level_cessation:_a_pragmatic_randomized_clinical_trial_ L2 - https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2014.177 DB - PRIME DP - Unbound Medicine ER -